Literature DB >> 14506035

Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.

B L Geller1, J D Deere, D A Stein, A D Kroeker, H M Moulton, P L Iversen.   

Abstract

Antisense phosphorodiamidate morpholino oligomers (PMOs) were tested for the ability to inhibit gene expression in Escherichia coli. PMOs targeted to either a myc-luciferase reporter gene product or 16S rRNA did not inhibit luciferase expression or growth. However, in a strain with defective lipopolysaccharide (lpxA mutant), which has a leaky outer membrane, PMOs targeted to the myc-luciferase or acyl carrier protein (acpP) mRNA significantly inhibited their targets in a dose-dependent response. A significant improvement was made by covalently joining the peptide (KFF)(3)KC to the end of PMOs. In strains with an intact outer membrane, (KFF)(3)KC-myc PMO inhibited luciferase expression by 63%. A second (KFF)(3)KC-PMO conjugate targeted to lacI mRNA induced beta-galactosidase in a dose-dependent response. The end of the PMO to which (KFF)(3)KC is attached affected the efficiency of target inhibition but in various ways depending on the PMO. Another peptide-lacI PMO conjugate was synthesized with the cationic peptide CRRRQRRKKR and was found not to induce beta-galactosidase. We conclude that the outer membrane of E. coli inhibits entry of PMOs and that (KFF)(3)KC-PMO conjugates are transported across both membranes and specifically inhibit expression of their genetic targets.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506035      PMCID: PMC201127          DOI: 10.1128/AAC.47.10.3233-3239.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

Review 1.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides.

Authors:  Y Shai
Journal:  Biochim Biophys Acta       Date:  1999-12-15

2.  Antimicrobial peptides of multicellular organisms.

Authors:  Michael Zasloff
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

3.  Antisense PNA effects in Escherichia coli are limited by the outer-membrane LPS layer.

Authors:  L Good; R Sandberg; O Larsson; P E Nielsen; C Wahlestedt
Journal:  Microbiology       Date:  2000-10       Impact factor: 2.777

Review 4.  Structure-function relationships of antimicrobial peptides.

Authors:  P M Hwang; H J Vogel
Journal:  Biochem Cell Biol       Date:  1998       Impact factor: 3.626

5.  c-Myc antisense limits rat liver regeneration and indicates role for c-Myc in regulating cytochrome P-450 3A activity.

Authors:  V Arora; D C Knapp; B L Smith; M L Statdfield; D A Stein; M T Reddy; D D Weller; P L Iversen
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

6.  Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA.

Authors:  L Good; P E Nielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 7.  Morpholino antisense oligomers: design, preparation, and properties.

Authors:  J Summerton; D Weller
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1997-06

8.  In vivo evaluation of a morpholino antisense oligomer directed against tumor necrosis factor-alpha.

Authors:  G Qin; M Taylor; Y Y Ning; P Iversen; L Kobzik
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2000-02

9.  In vivo protein transduction: delivery of a biologically active protein into the mouse.

Authors:  S R Schwarze; A Ho; A Vocero-Akbani; S F Dowdy
Journal:  Science       Date:  1999-09-03       Impact factor: 47.728

10.  Bactericidal antisense effects of peptide-PNA conjugates.

Authors:  L Good; S K Awasthi; R Dryselius; O Larsson; P E Nielsen
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

View more
  24 in total

1.  Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.

Authors:  Jesse Deere; Pat Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.

Authors:  Lucas D Tilley; Orion S Hine; Jill A Kellogg; Jed N Hassinger; Dwight D Weller; Patrick L Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 3.  Advances in therapeutic bacterial antisense biotechnology.

Authors:  John P Hegarty; David B Stewart
Journal:  Appl Microbiol Biotechnol       Date:  2017-12-05       Impact factor: 4.813

Review 4.  Next-generation precision antimicrobials: towards personalized treatment of infectious diseases.

Authors:  Cesar de la Fuente-Nunez; Marcelo Dt Torres; Francisco Jm Mojica; Timothy K Lu
Journal:  Curr Opin Microbiol       Date:  2017-06-14       Impact factor: 7.934

5.  Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection.

Authors:  Xin-Xing Tan; Jeffrey K Actor; Yin Chen
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers.

Authors:  James J Howard; Carolyn R Sturge; Dina A Moustafa; Seth M Daly; Kimberly R Marshall-Batty; Christina F Felder; Danniel Zamora; Marium Yabe-Gill; Maria Labandeira-Rey; Stacey M Bailey; Michael Wong; Joanna B Goldberg; Bruce L Geller; David E Greenberg
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

7.  Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis.

Authors:  Rekha G Panchal; Bruce L Geller; Brett Mellbye; Douglas Lane; Patrick L Iversen; Sina Bavari
Journal:  Nucleic Acid Ther       Date:  2012-09-14       Impact factor: 5.486

8.  Antisense growth inhibition of methicillin-resistant Staphylococcus aureus by locked nucleic acid conjugated with cell-penetrating peptide as a novel FtsZ inhibitor.

Authors:  Jingru Meng; Fei Da; Xue Ma; Ning Wang; Yukun Wang; Huinan Zhang; Mingkai Li; Ying Zhou; Xiaoyan Xue; Zheng Hou; Min Jia; Xiaoxing Luo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-24       Impact factor: 5.191

9.  Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers.

Authors:  Susan E Puckett; Kaleb A Reese; Georgi M Mitev; Valerie Mullen; Rudd C Johnson; Kyle R Pomraning; Brett L Mellbye; Lucas D Tilley; Patrick L Iversen; Michael Freitag; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2012-09-17       Impact factor: 5.191

10.  Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.

Authors:  Brett L Mellbye; Susan E Puckett; Luke D Tilley; Patrick L Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.